1 |
STEVENS W W, SCHLEIMER R P, KERN R C. Chronic rhinosinusitis with nasal polyps[J]. J. Allergy Clin. Immunol. Pract., 2016, 4(4): 565-572.
|
2 |
陈卓, 刘江怡, 陈杰, 等. 上皮细胞在鼻息肉形成和发展中的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(11): 1053-1056.
|
|
CHEN Z, LIU J Y, CHEN J, et al.. The role of epithelial cells in the formation and development of nasal polyps[J]. J. Clin. Otorhinolaryngol. Head Neck Surg., 2020, 34(11): 1053-1056.
|
3 |
WANG S B, CHEN S M, ZHU K S, et al.. Increased lipopolysaccharide content is positively correlated with glucocorticoid receptor-beta expression in chronic rhinosinusitis with nasal polyps[J]. Immun. Inflamm. Dis., 2020, 8(4): 605-614.
|
4 |
KANG R, ZENG L, ZHU S, et al.. Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis[J]. Cell Host Microbe, 2018, 24(1): 97-108.
|
5 |
CHEN R, KANG R, TANG D. The mechanism of HMGB1 secretion and release[J]. Exp. Mol. Med., 2022, 54(2): 91-102.
|
6 |
毛明峰. 沉默信号调节因子在慢性鼻窦炎伴鼻息肉中的表达[D]. 北京: 中国人民解放军医学院, 2014.
|
7 |
FU J, DENG W, GE J, et al.. Sirtuin 1 alleviates alcoholic liver disease by inhibiting HMGB1 acetylation and translocation[J/OL]. PeerJ, 2023, 11: e16480[2025-04-22]. .
|
8 |
伍新诚, 刘雨, 柏正平. 基于HMGB1介导的肺动脉平滑肌细胞焦亡探讨复方葶苈子汤治疗COPD-PH的作用机制[J].辽宁中医药大学学报, 2025, 27(1): 12-21.
|
|
WU X C, LIU Y, BAI Z P. Intervention mechanism of compound Tinglizi decoction on COPD-PH based on HMGB1-mediated pulmonary artery smooth muscle cell pyroptosis[J]. J. Liaoning Univ. Tradit. Chin. Med., 2025, 27(1):12-21.
|
9 |
陈黛诗. 高迁移率族蛋白1在慢性鼻窦炎伴鼻息肉中的表达及作用机制[D]. 北京: 中国人民解放军医学院, 2013.
|
10 |
BACHERT C, BHATTACHARYYA N, DESROSIERS M, et al.. Burden of disease in chronic rhinosinusitis with nasal polyps[J]. J. Asthma Allergy, 2021, 14: 127-134.
|
11 |
陈影影, 杨花荣, 吴云姣. 慢性鼻窦炎伴鼻息肉的临床治疗进展[J]. 医学理论与实践, 2023, 36(1): 37-39.
|
|
CHEN Y Y, YANG H R, WU Y J. Progress in clinical treatment of chronic sinusitis with nasal polyps[J]. J. Med. Theory Pract., 2023, 36(1): 37-39.
|
12 |
刘一潼, 周穗子, 邱前辉. NLRP3炎症小体在慢性鼻窦炎和变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 142-146+153.
|
|
LIU Y T, ZHOU S Z, QIU Q H. Research progress on NLRP3 inflammasome in chronic rhinosinusitis and allergic rhinitis[J]. J. Otolaryngol. Ophthalmol. Shandong Univ., 2022, 36(3): 142-146+153.
|
13 |
刘帆, 韩秀珍, 孙妍. Nod样受体蛋白3炎性小体及细胞焦亡在支气管哮喘中的作用[J]. 中华实用儿科临床杂志, 2020, 35(12): 955-957.
|
|
LIU F, HAN X Z, SUN Y. Role of Nod-like receptor pyrin domain 3 inflammasome and pyroptosis in bronchial asthma[J]. Chin. J. Appl. Clin. Pediatr., 2020, 35(12): 955-957.
|
14 |
程升浩. NOX2/ROS通过NLRP3炎性小体促进鼻黏膜上皮炎症在CRSwNP中的作用[D]. 长沙: 中南大学,2023.
|
15 |
YANG H, WANG H, ANDERSSON U. Targeting inflammation driven by HMGB1[J/OL]. Front. Immunol., 2020, 11: 484[2025-04-22]. .
|
16 |
DENG C, ZHAO L, YANG Z, et al.. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury[J]. Acta Pharmacol. Sin., 2022, 43(3): 520-528.
|
17 |
SAPPINGTON P L, YANG R, YANG H, et al.. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice[J]. Gastroenterology, 2002, 123(3): 790-802.
|
18 |
YANG R, ZHANG S, COTOIA A, et al.. High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicity[J/OL]. BMC Gastroenterol., 2012, 12: 45[2025-04-22]. .
|
19 |
PISETSKY D S. The translocation of nuclear molecules during inflammation and cell death[J]. Antioxid. Redox Signal., 2014, 20(7): 1117-1125.
|
20 |
LU B, ANTOINE D J, KWAN K, et al.. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation[J]. Proc. Natl. Acad. Sci. USA, 2014, 111(8): 3068-3073.
|
21 |
沈盼. SIRT1去乙酰化调控HMGB1在RA炎症中的作用及乌头汤的干预研究[D]. 武汉: 华中科技大学, 2022.
|
22 |
JIANG W, JIANG P, YANG R, et al.. Functional role of SIRT1-induced HMGB1 expression and acetylation in migration, invasion and angiogenesis of ovarian cancer[J]. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(14): 4431-4439.
|
23 |
YANG K, FAN M, WANG X, et al.. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis[J]. Cell Death Differ., 2022, 29(1): 133-146.
|